Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040093
Filing Date
2017-08-03
Accepted
2017-08-03 06:04:21
Documents
65
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471046_10-q.htm 10-Q 839814
2 EXHIBIT 10.1 v471046_ex10-1.htm EX-10.1 111992
3 EXHIBIT 31.1 v471046_ex31-1.htm EX-31.1 7983
4 EXHIBIT 31.2 v471046_ex31-2.htm EX-31.2 7965
5 EXHIBIT 32.1 v471046_ex32-1.htm EX-32.1 4215
  Complete submission text file 0001144204-17-040093.txt   5907611

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT icpt-20170630.xml EX-101.INS 1731858
7 XBRL TAXONOMY EXTENSION SCHEMA icpt-20170630.xsd EX-101.SCH 37186
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20170630_cal.xml EX-101.CAL 45950
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20170630_def.xml EX-101.DEF 102418
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20170630_lab.xml EX-101.LAB 294951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20170630_pre.xml EX-101.PRE 249445
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 171002640
SIC: 2834 Pharmaceutical Preparations